OpenVSafe by OpenVAERS
Search V-safe

B2G-26286-26370

3 vaccinations 12 coded responses 35 check-ins 12 free-text entries 6 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
330 / FL
Registered
2021-03-12
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-12
    Registered in v-safe
  2. 2021-03-12
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-12
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-03-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-03-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  6. 2021-03-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Headache · Be unable to do your normal daily activities
    Free text: Lightheaded
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Fever · Headache, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-03-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache · Be unable to work
    Adult check-in
  10. 2021-03-26
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-01
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-01
    Survey response — day 0, dose 2
    MedDRA: Dizziness — Feeling: Good · Site: Pain · Be unable to do your normal daily activities
    Free text: Dizzy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-04-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  16. 2021-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-04-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-04-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  19. 2021-04-08
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  20. 2021-04-16
    Survey response — day 14, dose 2
    MedDRA: Chest discomfort, Oropharyngeal pain — Feeling: Fair · Be unable to work
    Free text: Soar throat (hoarseness) tightness of chest
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-25
    Survey response — day 21, dose 2
    MedDRA: Arthralgia, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: I have rheumatoid arthritis and have been feeling more joint paint
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-04-25
    Report sent to call center — day 21, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-04-29
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-06
    Survey response — day 35, dose 2
    MedDRA: Breast neoplasm, Breast ulceration, Cyst, Heavy menstrual bleeding, Menstrual disorder — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Lesion on breastAbnormal menstrual cycles - increased bleeding and longer Abnormal cyst -
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-06
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-05-13
    Survey response — day 42, dose 2
    MedDRA: Ovarian cyst — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: 4cm ovarian cyst
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-05-13
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-07-01
    Survey response — 3 months, dose 2
    MedDRA: Fatigue, Menstruation irregular — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Irregular menstrual cycles, increased fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-07-01
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  30. 2021-07-06
  31. 2021-07-09
  32. 2021-09-30
    Survey response — 6 months, dose 2
    MedDRA: Menstrual disorder, Palpitations — Feeling: Fair · Be unable to work or attend school
    Free text: Heart palpitations, menstrual cycle changes
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-01-21
    Dose 3 — Pfizer-BioNTech
  34. 2022-01-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  35. 2022-01-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Fatigue or tiredness, Diarrhea
    Adult check-in
  36. 2022-01-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Muscle or body aches, Diarrhea
    Adult check-in
  37. 2022-01-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  38. 2022-01-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  39. 2022-01-30
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  40. 2022-02-13
    Survey response — day 21, dose 3
    MedDRA: Fatigue, Headache, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headaches, bad cycle and tired
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-02-22
    Survey response — day 28, dose 3
    MedDRA: Pain, Peripheral swelling — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Swelling in feet and pain
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-02-22
    Report sent to call center — day 28, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  43. 2022-02-25
    Survey response — day 35, dose 3
    MedDRA: Fatigue, Headache — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Headaches and fatigue
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-02-25
    Report sent to call center — day 35, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  45. 2022-03-01
  46. 2022-03-04
    Survey response — day 42, dose 3
    MedDRA: Headache, Menstrual disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Bad menstrual cycles and daily headaches
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-04-22
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  48. 2023-01-21
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-12Pfizer-BioNTech
22021-04-01Pfizer-BioNTech
32022-01-21Pfizer-BioNTech No

Call center

6 call center cases

6 unsuccessful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-15

Systemic reaction (other): Lightheaded

Release 6 — day 0, dose 2

2021-04-01

Systemic reaction (other): Dizzy

Release 7 — day 14, dose 2

2021-04-16

Symptoms: Soar throat (hoarseness) tightness of chest

Release 7 — day 21, dose 2

2021-04-25

Symptoms: I have rheumatoid arthritis and have been feeling more joint paint

Release 8 — day 35, dose 2

2021-05-06

Symptoms: Lesion on breastAbnormal menstrual cycles - increased bleeding and longer Abnormal cyst -

Release 8 — day 42, dose 2

2021-05-13

Symptoms: 4cm ovarian cyst

Release 9 — 3 months, dose 2

2021-07-01

Symptoms: Irregular menstrual cycles, increased fatigue

Release 9 — 6 months, dose 2

2021-09-30

Symptoms: Heart palpitations, menstrual cycle changes

Release 11 — day 21, dose 3

2022-02-13

Symptoms: Headaches, bad cycle and tired

Release 11 — day 28, dose 3

2022-02-22

Symptoms: Swelling in feet and pain

Release 11 — day 35, dose 3

2022-02-25

Symptoms: Headaches and fatigue

Release 11 — day 42, dose 3

2022-03-04

Symptoms: Bad menstrual cycles and daily headaches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDBreast neoplasm ✓ · ✓
SDBreast ulceration ○ ✓ ○
SDChest discomfort ✓ ✓ ✓
SDCyst ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache · · ✓
SDHeavy menstrual bleeding ✓ ✓ ✓
SDMenstrual disorder ✓ ✓ ✓
SDMenstruation irregular ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDOvarian cyst ✓ ✓ ✓
SDPain · · ✓
SDPalpitations · · ✓
SDPeripheral swelling · · ✓
SDPre-existing disease ✓ ✓ ✓
SDUnevaluable event · · ✓
SRODizziness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release